Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Ro Acquires Modern Fertility to Accelerate its Leadership in Women's Health
Ro, the healthcare technology company, today announced the acquisition of Modern Fertility, a high-growth reproductive health […]
Gamma Biosciences Acquires Controlling Stake in Mirus Bio
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced that […]
Digital Healthcare Company Healios Gets £7M to Offer Tailored Therapy to Children and Young People Across the UK
Based out of Southampton, Healios is a digital healthcare company working to empower patients and families affected […]
Novo Holdings Leads Series C in Hummingbird
Novo Holdings today announced that it has led the oversubscribed US$125 million Series C financing in Hummingbird […]
Pharmacy Quality Solutions (PQS) Welcomes Todd Sega as New CEO
Pharmacy Quality Solutions (PQS), a leading technology provider of pharmacy performance management services, announced today […]
AELIX Therapeutics Appoints Dr Melanie Rolli as CEO
AELIX Therapeutics S.L. (‘AELIX’), a clinical-stage biotechnology company specialized in the discovery and development of […]
BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter Strategic R&D Alliance
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, FUJIFILM […]
Cue Health Announces Completion of $235 Million Private Financing to Accelerate Growth
Cue Health Inc. (“Cue Health” or “Cue”), a health technology company, today announced the closing […]
Unmind Closes $47m Series B to Nurture and Improve the Mental Health of Organisations Around the World
Unmind, the leading workplace mental health platform, has closed a $47 million oversubscribed Series B […]
$50M Investment Caps DrFirst $135 Million Total
Health technology pioneer DrFirst today announced the closing of a $50 million equity investment from Sixth Street Growth, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more